In addition, the VLCD-induced reduction in fasting hyperglycemia was observed without any changes in hepatic ceramide content, hepatic inflammatory cytokine concentrations, or plasma concentrations of glucagon, corticosterone, or fibroblast growth factor-21 (FGF-21) [155]. The gene discussed is FGF21; the disease is Hyperglycemia.